Collaboration with AveXis led to the first licensed AAV therapeutic in the world. It took just 15 months from laboratory to manufacturing!
“We are especially grateful that BIA Separations shared, and operated, with the same sense of urgency we did to help bring gene therapy to the SMA community. BIA’s experience with AAV purification and its chromatographic technology were important contributions and we look forward to our continued work together.”
Former Senior Vice President of Technical Operations for AveXis